The apparent monovalency of human IgG4 is due to bispecificity

International Archives of Allergy and Immunology

Volumn 118, Issue 2-4, 1999, Pages 187-189

  Aalberse, Rob C ^a   Schuurman, Janine ^b   Van Ree, Ronald ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

Bispecific antibody; Chimeric antibody; IgG4; Non precipitating antibody

Indexed keywords

IMMUNOGLOBULIN G4; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; CONFERENCE PAPER; CROSS REACTION; IMMUNIZATION; PRIORITY JOURNAL;

EID: 0032964220     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024062     Document Type: Conference Paper

References (12)

1. Aalberse RC, Van Milligen FJ, Van't Hof W, Stapel SO: Allergen-specific IgG4 in atopic disease. Allergy 1993;48:559-569.
2. Van der Zee JS, Van Swieten P, Aalberse RC: Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol 1986;64:415-422.
3. Bergamaschini L, Santangelo T, Faricciotti A, Ciavarella N, Mannucci PM, Agostoni A: Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes. J Immunol 1996;156:1256-1261.
4. Van der Zee JS, Van Swieten P, Aalberse RC: Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immunol 1986;137:3566-3571.
5. Van Ree R, Stapel SO, Aalberse RC: Reverse-sandwich ELISA may underestimate antibody titers. J Allergy Clin Immunol 1989;84:562-563.
6. Margni RA, Borel IM: Paradoxical behavior of asymmetric IgG antibodies. Immunol Rev 1998;163:77-87.
7. Schuurman J: Chimeric Monoclonal antibodies to the Mite Allergen Der p 2: Valency Effects with IgE and IgG4. Thesis, University of Amsterdam, 1997.
8. Snow ME, Amzel LM: A molecular-mechanics study of the conformation of the interchain disulfide of human immunoglobulin G4 (IgG4). Mol Immunol 1988;25:1019-1024.
9. Angal S, King DJ, Bodmer MW, Turner A, Lawson ADG, Roberts G, Pedley B, Adair JR: A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol 1993;30:105-108.
10. Vaughn DE, Bjorkman PJ: Structural basis of pH-dependent antibody binding by the neonatal Fc receptor. Structure 1998;6:63-73.
11. Ghetie V, Ward ES: FcRn: The MHC class I-related receptor that is more than an IgG transporter. Immunol Today 1997;18:592-598.
12. Christianson GJ, Brooks W, Vekasi S, Manolfi EA, Niles J, Roopenian SL, Roths JB, Rothlein R, Roopenian DC: Beta 2-microglobulin-deficient mice are protected from hypergamma-globulinemia and have defective antibody responses because of increased IgG catabolism. J Immunol 1997;159:4781-4792.